vs
FTAI Infrastructure Inc.（FIP）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是FTAI Infrastructure Inc.的1.5倍（$219.9M vs $143.5M），Orthofix Medical Inc.净利率更高（-1.0% vs -68.1%，领先67.1%），FTAI Infrastructure Inc.同比增速更快（77.7% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-68.6M），过去两年FTAI Infrastructure Inc.的营收复合增速更高（31.9% vs 8.0%）
FTAI基础设施有限公司持有、运营并投资交通物流、中游能源、发电等核心领域的优质关键基础设施资产，主要面向北美市场，聚焦拥有稳定长期现金流、合同约定收入流的项目，为利益相关方创造可持续回报。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
FIP vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.5倍
$143.5M
营收增速更快
FIP
高出75.7%
2.0%
净利率更高
OFIX
高出67.1%
-68.1%
自由现金流更多
OFIX
多$85.5M
$-68.6M
两年增速更快
FIP
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $143.5M | $219.9M |
| 净利润 | $-97.7M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | -45.7% | 0.2% |
| 净利率 | -68.1% | -1.0% |
| 营收同比 | 77.7% | 2.0% |
| 净利润同比 | 21.6% | 92.4% |
| 每股收益（稀释后） | $-1.04 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FIPOFIX
| Q4 25 | $143.5M | $219.9M | ||
| Q3 25 | $140.6M | $205.6M | ||
| Q2 25 | $122.3M | $203.1M | ||
| Q1 25 | $96.2M | $193.6M | ||
| Q4 24 | $80.8M | $215.7M | ||
| Q3 24 | $83.3M | $196.6M | ||
| Q2 24 | $84.9M | $198.6M | ||
| Q1 24 | $82.5M | $188.6M |
净利润FIPOFIX
| Q4 25 | $-97.7M | $-2.2M | ||
| Q3 25 | $-104.5M | $-22.8M | ||
| Q2 25 | $-70.0M | $-14.1M | ||
| Q1 25 | $120.2M | $-53.1M | ||
| Q4 24 | $-124.7M | $-29.1M | ||
| Q3 24 | $-43.0M | $-27.4M | ||
| Q2 24 | $-48.1M | $-33.4M | ||
| Q1 24 | $-50.3M | $-36.0M |
毛利率FIPOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率FIPOFIX
| Q4 25 | -45.7% | 0.2% | ||
| Q3 25 | -70.8% | -8.3% | ||
| Q2 25 | -56.4% | -7.9% | ||
| Q1 25 | 81.8% | -25.2% | ||
| Q4 24 | -152.7% | -5.3% | ||
| Q3 24 | -51.7% | -9.6% | ||
| Q2 24 | -56.4% | -12.5% | ||
| Q1 24 | -58.8% | -15.6% |
净利率FIPOFIX
| Q4 25 | -68.1% | -1.0% | ||
| Q3 25 | -74.4% | -11.1% | ||
| Q2 25 | -57.2% | -6.9% | ||
| Q1 25 | 125.0% | -27.4% | ||
| Q4 24 | -154.4% | -13.5% | ||
| Q3 24 | -51.6% | -13.9% | ||
| Q2 24 | -56.7% | -16.8% | ||
| Q1 24 | -60.9% | -19.1% |
每股收益（稀释后）FIPOFIX
| Q4 25 | $-1.04 | $-0.05 | ||
| Q3 25 | $-1.38 | $-0.57 | ||
| Q2 25 | $-0.73 | $-0.36 | ||
| Q1 25 | $0.89 | $-1.35 | ||
| Q4 24 | $-1.21 | $-0.76 | ||
| Q3 24 | $-0.45 | $-0.71 | ||
| Q2 24 | $-0.52 | $-0.88 | ||
| Q1 24 | $-0.54 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.4M | $82.0M |
| 总债务越低越好 | $3.8B | — |
| 股东权益账面价值 | $21.3M | $450.0M |
| 总资产 | $5.7B | $850.6M |
| 负债/权益比越低杠杆越低 | 176.99× | — |
8季度趋势，按日历期对齐
现金及短期投资FIPOFIX
| Q4 25 | $57.4M | $82.0M | ||
| Q3 25 | $34.7M | $62.9M | ||
| Q2 25 | $33.6M | $65.6M | ||
| Q1 25 | $26.3M | $58.0M | ||
| Q4 24 | $27.8M | $83.2M | ||
| Q3 24 | $20.3M | $30.1M | ||
| Q2 24 | $33.1M | $26.4M | ||
| Q1 24 | $23.0M | $27.0M |
总债务FIPOFIX
| Q4 25 | $3.8B | — | ||
| Q3 25 | $3.7B | $157.2M | ||
| Q2 25 | $3.1B | $157.0M | ||
| Q1 25 | $2.8B | $156.9M | ||
| Q4 24 | $1.6B | $157.0M | ||
| Q3 24 | $1.5B | $118.5M | ||
| Q2 24 | $1.6B | $118.0M | ||
| Q1 24 | $1.3B | $118.2M |
股东权益FIPOFIX
| Q4 25 | $21.3M | $450.0M | ||
| Q3 25 | $181.1M | $442.5M | ||
| Q2 25 | $375.5M | $458.3M | ||
| Q1 25 | $476.2M | $458.3M | ||
| Q4 24 | $202.7M | $503.1M | ||
| Q3 24 | $370.8M | $525.9M | ||
| Q2 24 | $394.8M | $546.0M | ||
| Q1 24 | $402.5M | $570.3M |
总资产FIPOFIX
| Q4 25 | $5.7B | $850.6M | ||
| Q3 25 | $5.5B | $832.6M | ||
| Q2 25 | $4.4B | $837.2M | ||
| Q1 25 | $4.1B | $823.1M | ||
| Q4 24 | $2.4B | $893.3M | ||
| Q3 24 | $2.4B | $867.9M | ||
| Q2 24 | $2.5B | $882.0M | ||
| Q1 24 | $2.3B | $906.0M |
负债/权益比FIPOFIX
| Q4 25 | 176.99× | — | ||
| Q3 25 | 20.59× | 0.36× | ||
| Q2 25 | 8.21× | 0.34× | ||
| Q1 25 | 5.79× | 0.34× | ||
| Q4 24 | 7.84× | 0.31× | ||
| Q3 24 | 4.14× | 0.23× | ||
| Q2 24 | 3.94× | 0.22× | ||
| Q1 24 | 3.34× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-68.6M | $16.8M |
| 自由现金流率自由现金流/营收 | -47.8% | 7.6% |
| 资本支出强度资本支出/营收 | 45.9% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-398.5M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流FIPOFIX
| Q4 25 | $-2.8M | $27.7M | ||
| Q3 25 | $-24.4M | $12.4M | ||
| Q2 25 | $-5.2M | $11.6M | ||
| Q1 25 | $-85.7M | $-18.4M | ||
| Q4 24 | $-8.1M | $23.7M | ||
| Q3 24 | $14.2M | $11.7M | ||
| Q2 24 | $-17.6M | $9.0M | ||
| Q1 24 | $-3.9M | $-18.6M |
自由现金流FIPOFIX
| Q4 25 | $-68.6M | $16.8M | ||
| Q3 25 | $-90.7M | $2.5M | ||
| Q2 25 | $-87.5M | $4.5M | ||
| Q1 25 | $-151.7M | $-25.1M | ||
| Q4 24 | $-34.3M | $15.2M | ||
| Q3 24 | $-11.7M | $6.3M | ||
| Q2 24 | $-32.1M | $-360.0K | ||
| Q1 24 | $-16.7M | $-29.1M |
自由现金流率FIPOFIX
| Q4 25 | -47.8% | 7.6% | ||
| Q3 25 | -64.5% | 1.2% | ||
| Q2 25 | -71.6% | 2.2% | ||
| Q1 25 | -157.7% | -13.0% | ||
| Q4 24 | -42.4% | 7.0% | ||
| Q3 24 | -14.0% | 3.2% | ||
| Q2 24 | -37.9% | -0.2% | ||
| Q1 24 | -20.3% | -15.4% |
资本支出强度FIPOFIX
| Q4 25 | 45.9% | 4.9% | ||
| Q3 25 | 47.2% | 4.8% | ||
| Q2 25 | 67.3% | 3.5% | ||
| Q1 25 | 68.6% | 3.5% | ||
| Q4 24 | 32.5% | 4.0% | ||
| Q3 24 | 31.1% | 2.7% | ||
| Q2 24 | 17.2% | 4.7% | ||
| Q1 24 | 15.6% | 5.6% |
现金转化率FIPOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FIP
| Power Revenues | $45.9M | 32% |
| Rail Revenue | $44.6M | 31% |
| Service Other | $22.8M | 16% |
| Gas Revenues | $15.3M | 11% |
| Roadside Services Revenues | $11.5M | 8% |
| Rapauno | $1.2M | 1% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
